Concepedia

Line Schmidt Tarpgaard

LS

16

Publications

2.1K

Citations

13

H-Index

2013

Active since

Affiliations

Odense University Hospital(Current)

University of Southern Denmark

University of Copenhagen

Herlev Hospital

Region of Southern Denmark

Line Schmidt Tarpgaard is an author at Odense University Hospital specializing in oncology, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2013–2023

16

Publications

16

Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer

Scott Kopetz, Axel Grothey, Rona Yaeger et al. · New England Journal of Medicine · 2019 · 1.4K citations · Full text

Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance

Niels F. Jensen, Jan Stenvang, Mette K. Beck et al. · Molecular Oncology · 2015 · 136 citations · Full text

miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells

Mads H. Rasmussen, Iben Lyskjær, Rosa Jersie-Christensen et al. · Nature Communications · 2016 · 91 citations · Full text

Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer

Mogens K. Boisen, Julia S. Johansen, Christian Dehlendorff et al. · Annals of Oncology · 2013 · 87 citations · Full text

, , +6

High expression of microRNA‐625‐3p is associated with poor response to first‐line oxaliplatin based treatment of metastatic colorectal cancer

Mads H. Rasmussen, Niels F. Jensen, Line Schmidt Tarpgaard et al. · Molecular Oncology · 2013 · 86 citations · Full text

Rows per page

1–5 of 16